Highlights

  • First real-world assessment of India's Covid-19 vaccine
  • Study conducted during the second wave when Delta was dominant strain
  • During clinical trial Covaxin had 65% efficacy against Delta

Latest news

An important message from the heart for all you 'social' drinkers out there!

An important message from the heart for all you 'social' drinkers out there!

Omicron variant | Intensive containment, active surveillance, increased vaccination: Centre to states

Omicron variant | Intensive containment, active surveillance, increased vaccination: Centre to states

Oppo Reno7, Reno7 Pro, Reno7 SE launched in China: check specs and price

Oppo Reno7, Reno7 Pro, Reno7 SE launched in China: check specs and price

'I am done! Goodbye! INJUSTICE': comedian Munawar Faruqui hints at quitting comedy

'I am done! Goodbye! INJUSTICE': comedian Munawar Faruqui hints at quitting comedy

Heartbreak for Thailand as ICC cancels Women's World Cup Qualifier

Heartbreak for Thailand as ICC cancels Women's World Cup Qualifier

Covaxin is 50% effective against Delta variant of Covid-19, says new study

Covaxin had 77.8% efficacy against symptomatic Covid-19 disease and present no serious safety concerns during the clinical trials

Two doses of Covaxin are 50 per cent effective against the symptomatic disease, according to the first real-world assessment of India's indigenous Covid-19 vaccine published in The Lancet Infectious Diseases journal.

Results of an interim study recently published in The Lancet showed that two doses of Covaxin, also known as BBV152, had 77.8 per cent efficacy against symptomatic disease and present no serious safety concerns.

Also watch | Germany Covid surge: 'you'll be vaccinated or dead', govt warns citizens

The latest study assessed 2,714 hospital workers at the All India Institute of Medical Sciences (AIIMS) in Delhi, from April 15–May 15, who were symptomatic and underwent RT-PCR test for Covid-19 detection.

Researchers noted that the Delta variant was the dominant strain in India during the study period, accounting for approximately 80 per cent of all confirmed Covid-19 cases.

Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the National Institute of Virology, Indian Council of Medical Research (NIV-ICMR), Pune, is an inactivated whole virus vaccine administered in a two-dose regimen, 28 days apart.

In January this year, Covaxin was approved for emergency use in India for people aged 18 and above. The World Health Organization (WHO) added the vaccine to its list of approved emergency use COVID-19 vaccines earlier this month.

The latest study was conducted during India's second Covid-19 surge and in healthcare workers who were primarily offered Covaxin.

"Our study offers a more complete picture of how BBV152 (Covaxin) performs in the field and should be considered in the context of COVID-19 surge conditions in India, combined with the possible immune evasive potential of the Delta variant," said Manish Soneja, Additional Professor of Medicine at AIIMS New Delhi.

"Our findings add to the growing body of evidence that rapid vaccine rollout programmes remain the most promising path to pandemic control while public health policies must continue to include additional protective measures, such as mask-wearing and social distancing," Soneja said in a statement.

Up Next

Covaxin is 50% effective against Delta variant of Covid-19, says new study

Covaxin is 50% effective against Delta variant of Covid-19, says new study

Omicron variant | Intensive containment, active surveillance, increased vaccination: Centre to states

Omicron variant | Intensive containment, active surveillance, increased vaccination: Centre to states

'I am done! Goodbye! INJUSTICE': comedian Munawar Faruqui hints at quitting comedy

'I am done! Goodbye! INJUSTICE': comedian Munawar Faruqui hints at quitting comedy

Pandemic is not over yet, warns PM Modi as new variant raises concerns

Pandemic is not over yet, warns PM Modi as new variant raises concerns

Experts' description of 'Omicron' variant raises concern

Experts' description of 'Omicron' variant raises concern

Heavy rains continue to lash Chennai, intensity to reduce from Sunday predict weather experts

Heavy rains continue to lash Chennai, intensity to reduce from Sunday predict weather experts

More videos

PM Modi chairs all-party meet ahead of winter session; repeal to crypto - a heavy agenda ahead
Variant scare pushes states to issue new rules for travellers, here is what you need to know
Delhi Choking: Records highest pollution days in November with AQI severe for 11 days
Legislature does not assess impact of laws before passing them: Chief Justice
Farmer unions suspend November 29 tractor rally to Parliament
Bad vaccination figures can’t be hidden behind one man’s photo: Rahul Gandhi
Quarantine on arrival in Mumbai for passengers from South Africa: Mayor
Bill to repeal three farm laws to be tabled on first day of winter session: Centre
Omicron variant: PM Modi discusses travel curbs as world races to fight new Covid-19 strain
Conspiracy to frame me: Maharashtra minister Nawab Malik after 'recce' tweet